The company will not receive any proceeds from the sale of shares of common stock by the selling stockholders.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEXX:
- Lexaria Bioscience Expands Strategic Outreach and Secures New Patents
- Lexaria Bioscience engages advisory firm to identify new business opportunities
- Lexaria Bioscience Secures $4 Million for R&D Expansion
- Lexaria Bioscience announces $4M registered direct offering priced ATM
- Lexaria Bioscience prices 2.7M shares at $1.50 in registered direct offering